219 filings
Page 5 of 11
8-K
7qv9gvlwih6gf
10 Aug 20
PRE-NDA (NEW DRUG APPLICATION) MEETING GRANTED for Bardoxolone
6:51am
8-K
dpkdrfjojo10emxp2
30 Jul 20
Reata Announces the Appointment of Martin W. Edwards, M.D. to Its Board of Directors
9:16pm
8-K
mlqr2amqmbrcb
7 Jul 20
Reata Announces promotion and New hires for key leadership roles
6:50am
D
gc5p32wro5t b78qppzc
25 Jun 20
$50M in equity, sold $50M, 2 investors
5:07pm
8-K
kqrb4a7qlkj
24 Jun 20
Reata PHARMACEUTICALS, Inc. CLOSES $350 Million strategic investment from blackstone life sciences
10:23am
8-K
eepl8
11 Jun 20
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
3wljcti2haq5z873dhi
11 Jun 20
Reata Pharmaceuticals, Inc. and Blackstone Life Sciences Announce $350 Million Strategic Investment
9:26am
8-K
efw5e2juh fqnwy3s
2 Jun 20
Departure of Directors or Certain Officers
4:05pm
8-K
3fl8ldb n9ewna3m
11 May 20
Reata pharmaceuticals, inc. announces FIRST quarter 2020 financial RESULTS and provides an update on development programs
4:06pm
DEFA14A
v9mew aoyzqc4f2h6f4
29 Apr 20
Additional proxy soliciting materials
6:10am
S-8
9bpmo ez0
26 Feb 20
Registration of securities for employees
4:06pm
8-K
qho2mdbmtnf78rq
19 Feb 20
Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2019 Financials and ProvideS an Update on Development Programs
4:03pm
SEC STAFF
zpzz 410y2
18 Feb 20
SEC staff action: Order
12:00am
SEC STAFF
lzkqv
5 Feb 20
SEC staff action: Order
12:00am
8-K
3q6c73m4qc uk
20 Dec 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:05pm
8-K
ljcnfl fvk09ny
14 Nov 19
Entry into a Material Definitive Agreement
5:00pm